These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36883603)

  • 21. Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic.
    Adnine A; Nadiri K; Soussan I; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021; 17(3):303-311. PubMed ID: 33504309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study. World Health Organization. International League of Associations for Rheumatology. Community Oriented Programme for the Control of the Rheumatic Diseases.
    Dans LF; Tankeh-Torres S; Amante CM; Penserga EG
    J Rheumatol; 1997 Sep; 24(9):1814-9. PubMed ID: 9292809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology.
    Zanetti A; Carrara G; Landolfi G; Rozza D; Chighizola CB; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L; Raffeiner B; Lomater C; Caprioli M; Fredi M; Romeo N; Cuomo G; Vadacca M; Scirè CA;
    Clin Exp Rheumatol; 2022 Nov; 40(11):2038-2043. PubMed ID: 35260224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatologic Aspects of the COVID-19 Pandemic: A Practical Resource for Physicians in Kuwait and the Gulf region as Recommended by the Kuwait Association of Rheumatology.
    Baron F; Alhajeri H; Abutiban F; Almutairi M; Alawadhi A; Aldei A; Alherz A; Ali Y; Alsayegh S; Dehrab A; Ghanem A; Hajji E; Hayat S; Saleh K; Shaikh-Alsooq R; Tarakmah H; Albasri A; Alenezi A; Alhadhood N; Alkanderi W; Almathkoori A; Almutairi N; Alturki A; Alkadi A; Behbahani H
    Curr Rheumatol Rev; 2022; 18(2):108-116. PubMed ID: 34620059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remotely delivered physiotherapy: can we capture the benefits beyond COVID-19?
    Bearne LM; Gregory WJ; Hurley MV
    Rheumatology (Oxford); 2021 Apr; 60(4):1582-1584. PubMed ID: 33547773
    [No Abstract]   [Full Text] [Related]  

  • 26. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
    Akintayo RO; Bahiri R; El Miedany Y; Olaosebikan H; Kalla AA; Adebajo AO; Migowa AN; Slimani S; Koussougbo OD; Kawther BA; Akpabio AA; Ghozlani I; Dey D; Hassan WA; Govind N; Makan K; Mohamed A; Genga EK; Ghassem MKA; Mortada M; Hamdi W; Wabi MO; Tikly M; Ngandeu-Singwe M; Scott C
    Clin Rheumatol; 2021 Sep; 40(9):3445-3454. PubMed ID: 32876786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease.
    Koppert TY; Jacobs JWG; Geenen R
    Rheumatology (Oxford); 2021 Aug; 60(8):3709-3715. PubMed ID: 33313870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic.
    Fragoulis GE; Evangelatos G; Arida A; Bournia VK; Fragiadaki K; Karamanakos A; Kravvariti E; Laskari K; Panopoulos S; Pappa M; Tektonidou MG; Sfikakis PP
    Ann Rheum Dis; 2021 Apr; 80(4):e60. PubMed ID: 32475830
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.
    Mukusheva Z; Assylbekova M; Poddighe D
    Rheumatol Int; 2020 Aug; 40(8):1351-1352. PubMed ID: 32514608
    [No Abstract]   [Full Text] [Related]  

  • 30. SARS-CoV-2 test patterns in Danish patients with inflammatory rheumatic diseases during the COVID-19 pandemic.
    Alzubaidi A; Cordtz R; Westermann R; Soussi BG; Lauridsen KB; Kristensen S; Dreyer L
    Scand J Rheumatol; 2023 May; 52(3):321-323. PubMed ID: 36632996
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey.
    Eriksen TE; Dinesen WKH; Uhrenholt L; Dreyer L; Duch K; Kristensen S
    Rheumatol Int; 2022 May; 42(5):783-790. PubMed ID: 35359192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.
    Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
    Ann Rheum Dis; 2021 Jul; 80(7):953-954. PubMed ID: 33622689
    [No Abstract]   [Full Text] [Related]  

  • 33. Musculoskeletal disorders--disease burden and challenges in the developing world.
    Gcelu A; Kalla AA
    S Afr Med J; 2015 Dec; 105(12):1070-1. PubMed ID: 26933718
    [No Abstract]   [Full Text] [Related]  

  • 34. Providing Rheum with a View.
    Mandell BF
    Med Clin North Am; 2021 Mar; 105(2):xv-xvi. PubMed ID: 33589112
    [No Abstract]   [Full Text] [Related]  

  • 35. [Not Available].
    Burmester GR
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S2. PubMed ID: 26536183
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study.
    Smith TO; Belderson P; Dainty JR; Birt L; Durrant K; Chipping JR; Tsigarides J; Yates M; Naughton F; Werry S; Notley C; Shepstone L; MacGregor AJ
    BMJ Open; 2021 Jun; 11(6):e048772. PubMed ID: 34083347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public interest in musculoskeletal symptoms and disorders during the COVID-19 pandemic : Infodemiology study.
    Kardeş S; Erdem A; Gürdal H
    Z Rheumatol; 2022 Apr; 81(3):247-252. PubMed ID: 33779835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.
    Xiao F; Han M; Zhu X; Tang Y; Huang E; Zou H; Jiang Q; Lu L
    Mod Rheumatol; 2021 Sep; 31(5):927-932. PubMed ID: 33427554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fate of the patient with musculoskeletal disorders in Italy: an epidemiological insight.
    Cimmino MA; Salaffi F
    Clin Exp Rheumatol; 2007; 25(6):803-5. PubMed ID: 18173911
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1).
    Harrison SR; Garrido-Cumbrera M; Navarro-Compán V; Correa-Fernández J; Webb D; Christen L; Marzo-Ortega H
    Rheumatol Adv Pract; 2021; 5(3):rkab098. PubMed ID: 34988357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.